Awareness Enhancing Interventions

NCT ID: NCT04683510

Last Updated: 2025-05-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

4451 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-12

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if increasing awareness and, thus, enhancing positive attitudes about research, prior to recruitment attempts, will increase participation in cancer clinical research among African American (AA) cancer survivors so that recruitment efforts can focus on the most optimal and cost- effective approaches

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this project, 2000 AA potential AMPLIFI project participants will be randomized to the awareness-enhancing intervention (AWEI) or to the comparison condition in which they do not receive AWEI intervention but only the Adapting Multiple Behavior Interventions that Effectively Improve Cancer Survivor Health (AMPLIFI) basic recruitment strategy (No AWEI). Randomization for the AWEI Randomized Controlled Trial (RCT) will occur soon after the AMPLIFI recruitment letter is sent, and AWEI interventions will be delivered over a two-week period between the AMPLIFI recruitment invitation letter and the AMPLIFI recruitment call. Survivors randomized to AWEI intervention will be exposed to 8 different combinations of the AWEI components according to different types of strategies and type of information reflecting the survivor voice or not. Subsequent to the AMPLIFI recruitment call, a 20% random sample of cancer survivors will be surveyed over the phone to assess intervention fidelity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Research Awareness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

AMPLIFI recruitment process, 1600 AA cancer survivors will be randomized to one of 8 conditions that vary by type of strategy, type of information, and type of perspective (survivor or researcher "voice") and 400 randomized to the basic recruitment strategy
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

This group will receive no intervention before receiving the AMPLIFI Recruitment Call

Group Type NO_INTERVENTION

No interventions assigned to this group

Navigation

After receiving recruitment letter from AMPLIFI, participant randomized to this arm will receive a phone call from a Research Specialist who will discuss the importance of research participation for cancer survivors to increase research awareness and aid in recruitment. The information will focus on the importance of research and will be delivered from the perspective of either a researcher or a cancer survivor.

Group Type OTHER

Navigation - Study Specific - Researcher Voice

Intervention Type OTHER

The intervention is delivered over the telephone

Navigation - Study Specific - Cancer Survivor Voice

Intervention Type OTHER

The intervention is delivered over the telephone

Navigation - Research General - Researcher Voice

Intervention Type OTHER

The intervention is delivered over the telephone

Navigation - Research General - Cancer Survivor Voice

Intervention Type OTHER

The intervention is delivered over the telephone

Brochure

After receiving recruitment letter from AMPLIFI, participant randomized to this arm will receive a brochure which will focus on the importance of research participation for cancer survivors in order to increase research awareness and aid in recruitment.

Group Type OTHER

Brochure - Study Specific - Researcher Voice

Intervention Type OTHER

The invention is mailed to the participant in a brochure.

Brochure - Study Specific - Cancer Survivor Voice

Intervention Type OTHER

The invention is mailed to the participant in a brochure.

Brochure - Research General - Researcher Voice

Intervention Type OTHER

The invention is mailed to the participant in a brochure.

Brochure - Research General - Cancer Survivor Voice

Intervention Type OTHER

The invention is mailed to the participant in a brochure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Navigation - Study Specific - Researcher Voice

The intervention is delivered over the telephone

Intervention Type OTHER

Navigation - Study Specific - Cancer Survivor Voice

The intervention is delivered over the telephone

Intervention Type OTHER

Navigation - Research General - Researcher Voice

The intervention is delivered over the telephone

Intervention Type OTHER

Navigation - Research General - Cancer Survivor Voice

The intervention is delivered over the telephone

Intervention Type OTHER

Brochure - Study Specific - Researcher Voice

The invention is mailed to the participant in a brochure.

Intervention Type OTHER

Brochure - Study Specific - Cancer Survivor Voice

The invention is mailed to the participant in a brochure.

Intervention Type OTHER

Brochure - Research General - Researcher Voice

The invention is mailed to the participant in a brochure.

Intervention Type OTHER

Brochure - Research General - Cancer Survivor Voice

The invention is mailed to the participant in a brochure.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* African American/Black
* adults (age ≥50 years old)
* diagnosed with obesity/physical activity associated cancers that have a 70% or greater 5-year relative cancer-free survival rate multiple myeloma, localized kidney cancer and loco- regional cancers of the colorectum, female breast, prostate, endometrium, and ovary).
* 1-5 years post diagnosis
* reside in an area with wireless coverage
* In the AMPLIFI recruitment pool
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role collaborator

University of Tennessee

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

MICHELLE Y MARTIN

Director: Center for Innovation in Health Equity Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michelle Y Marttin, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Tennessee

Maria Pisu, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

University of Tennessee Health Science Center

Memphis, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Bester N, Di Vito-Smith M, McGarry T, Riffkin M, Kaehler S, Pilot R, Bwire R. The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-Care Professionals. Adv Ther. 2016 Feb;33(2):167-77. doi: 10.1007/s12325-016-0284-y. Epub 2016 Jan 23.

Reference Type BACKGROUND
PMID: 26801772 (View on PubMed)

Beskow LM, Sandler RS, Millikan RC, Weinberger M. Patient perspectives on research recruitment through cancer registries. Cancer Causes Control. 2005 Dec;16(10):1171-5. doi: 10.1007/s10552-005-0407-2.

Reference Type BACKGROUND
PMID: 16215867 (View on PubMed)

Wenzel JA, Mbah O, Xu J, Moscou-Jackson G, Saleem H, Sakyi K, Ford JG. A Model of Cancer Clinical Trial Decision-making Informed by African-American Cancer Patients. J Racial Ethn Health Disparities. 2015 Jun;2(2):192-9. doi: 10.1007/s40615-014-0063-x.

Reference Type BACKGROUND
PMID: 25960945 (View on PubMed)

Doak LG, Doak CC, Meade CD. Strategies to improve cancer education materials. Oncol Nurs Forum. 1996 Sep;23(8):1305-12.

Reference Type BACKGROUND
PMID: 8883075 (View on PubMed)

Ford JG, Howerton MW, Bolen S, Gary TL, Lai GY, Tilburt J, Gibbons MC, Baffi C, Wilson RF, Feuerstein CJ, Tanpitukpongse P, Powe NR, Bass EB. Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evid Rep Technol Assess (Summ). 2005 Jun;(122):1-11. doi: 10.1037/e439572005-001. No abstract available.

Reference Type BACKGROUND
PMID: 15989377 (View on PubMed)

Hughes TB, Varma VR, Pettigrew C, Albert MS. African Americans and Clinical Research: Evidence Concerning Barriers and Facilitators to Participation and Recruitment Recommendations. Gerontologist. 2017 Apr 1;57(2):348-358. doi: 10.1093/geront/gnv118.

Reference Type BACKGROUND
PMID: 26553736 (View on PubMed)

Kamen CS, Quinn GP, Asare M, Heckler CE, Guido JJ, Giguere JK, Gilliland K, Liu JJ, Geer J, Delacroix SE, Morrow GR, Jacobsen PB. Multimedia psychoeducation for patients with cancer who are eligible for clinical trials: A randomized clinical trial. Cancer. 2018 Dec 1;124(23):4504-4511. doi: 10.1002/cncr.31771. Epub 2018 Oct 6.

Reference Type BACKGROUND
PMID: 30291797 (View on PubMed)

Fouad MN, Acemgil A, Bae S, Forero A, Lisovicz N, Martin MY, Oates GR, Partridge EE, Vickers SM. Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials. J Oncol Pract. 2016 Jun;12(6):556-63. doi: 10.1200/JOP.2015.008946. Epub 2016 May 17.

Reference Type BACKGROUND
PMID: 27189356 (View on PubMed)

Ward EM, Sherman RL, Henley SJ, Jemal A, Siegel DA, Feuer EJ, Firth AU, Kohler BA, Scott S, Ma J, Anderson RN, Benard V, Cronin KA. Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 Years. J Natl Cancer Inst. 2019 Dec 1;111(12):1279-1297. doi: 10.1093/jnci/djz106.

Reference Type BACKGROUND
PMID: 31145458 (View on PubMed)

Wissing MD, Kluetz PG, Ning YM, Bull J, Merenda C, Murgo AJ, Pazdur R. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013. Cancer. 2014 Oct 1;120(19):3025-32. doi: 10.1002/cncr.28809. Epub 2014 Jun 25.

Reference Type BACKGROUND
PMID: 24965506 (View on PubMed)

Shenoy D, Packianathan S, Chen AM, Vijayakumar S. Do African-American men need separate prostate cancer screening guidelines? BMC Urol. 2016 May 10;16(1):19. doi: 10.1186/s12894-016-0137-7.

Reference Type BACKGROUND
PMID: 27165293 (View on PubMed)

Ewing AT, Kalu N, Cain G, Erby LH, Ricks-Santi LJ, Tetteyfio-Kidd Telemaque E, Scott DM. Factors associated with willingness to provide biospecimens for genetics research among African American cancer survivors. J Community Genet. 2019 Oct;10(4):471-480. doi: 10.1007/s12687-019-00411-0. Epub 2019 Mar 14.

Reference Type BACKGROUND
PMID: 30877487 (View on PubMed)

Rivers D, August EM, Sehovic I, Lee Green B, Quinn GP. A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials. 2013 Jul;35(2):13-32. doi: 10.1016/j.cct.2013.03.007. Epub 2013 Apr 1.

Reference Type BACKGROUND
PMID: 23557729 (View on PubMed)

Rick J, Graffy J, Knapp P, Small N, Collier DJ, Eldridge S, Kennedy A, Salisbury C, Treweek S, Torgerson D, Wallace P, Madurasinghe V, Hughes-Morley A, Bower P. Systematic techniques for assisting recruitment to trials (START): study protocol for embedded, randomized controlled trials. Trials. 2014 Oct 25;15:407. doi: 10.1186/1745-6215-15-407.

Reference Type BACKGROUND
PMID: 25344684 (View on PubMed)

Treweek S, Lockhart P, Pitkethly M, Cook JA, Kjeldstrom M, Johansen M, Taskila TK, Sullivan FM, Wilson S, Jackson C, Jones R, Mitchell ED. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open. 2013 Feb 7;3(2):e002360. doi: 10.1136/bmjopen-2012-002360. Print 2013.

Reference Type BACKGROUND
PMID: 23396504 (View on PubMed)

Madurasinghe VW; Sandra Eldridge on behalf of MRC START Group and Gordon Forbes on behalf of the START Expert Consensus Group. Guidelines for reporting embedded recruitment trials. Trials. 2016 Jan 14;17:27. doi: 10.1186/s13063-015-1126-y.

Reference Type BACKGROUND
PMID: 26767365 (View on PubMed)

Pisu M, Demark-Wahnefried W, Kenzik KM, Oster RA, Lin CP, Manne S, Alvarez R, Martin MY. A dance intervention for cancer survivors and their partners (RHYTHM). J Cancer Surviv. 2017 Jun;11(3):350-359. doi: 10.1007/s11764-016-0593-9. Epub 2017 Jan 9.

Reference Type BACKGROUND
PMID: 28070770 (View on PubMed)

Martin MY, Pollack LA, Evans MB, Smith JL, Kratt P, Prayor-Patterson H, Watson CD, Dignan M, Cheney LC, Pisu M, Liwo A, Hullett S. Tailoring cancer education and support programs for low-income, primarily African American cancer survivors. Oncol Nurs Forum. 2011 Jan;38(1):E55-9. doi: 10.1188/11.ONF.E55-E59.

Reference Type BACKGROUND
PMID: 21186152 (View on PubMed)

Pisu M, Martin MY, Shewchuk R, Meneses K. Dealing with the financial burden of cancer: perspectives of older breast cancer survivors. Support Care Cancer. 2014 Nov;22(11):3045-52. doi: 10.1007/s00520-014-2298-9. Epub 2014 Jun 10.

Reference Type BACKGROUND
PMID: 24912858 (View on PubMed)

Pisu M, Azuero A, Halilova KI, Williams CP, Kenzik KM, Kvale EA, Williams GR, Meneses K, Sullivan M, Yagnik SK, Goertz HP, Rocque GB. Most impactful factors on the health-related quality of life of a geriatric population with cancer. Cancer. 2018 Feb 1;124(3):596-605. doi: 10.1002/cncr.31048. Epub 2017 Dec 18.

Reference Type BACKGROUND
PMID: 29250775 (View on PubMed)

Pisu M, Schoenberger YM, Herbey I, Brown-Galvan A, Liang MI, Riggs K, Meneses K. Perspectives on Conversations About Costs of Cancer Care of Breast Cancer Survivors and Cancer Center Staff: A Qualitative Study. Ann Intern Med. 2019 May 7;170(9_Suppl):S54-S61. doi: 10.7326/M18-2117.

Reference Type BACKGROUND
PMID: 31060056 (View on PubMed)

Martin MY, Evans MB, Kratt P, Pollack LA, Smith JL, Oster R, Dignan M, Prayor-Patterson H, Watson C, Houston P, Andrews S, Liwo A, Tseng TS, Hullett S, Oliver J, Pisu M. Meeting the information needs of lower income cancer survivors: results of a randomized control trial evaluating the american cancer society's "I can cope". J Health Commun. 2014 Apr;19(4):441-59. doi: 10.1080/10810730.2013.821557. Epub 2014 Jan 16.

Reference Type BACKGROUND
PMID: 24433231 (View on PubMed)

Fouad M, Wynn T, Martin M, Partridge E. Patient navigation pilot project: results from the Community Health Advisors in Action Program (CHAAP). Ethn Dis. 2010 Spring;20(2):155-61.

Reference Type BACKGROUND
PMID: 20503896 (View on PubMed)

Dignan M, Evans M, Kratt P, Pollack LA, Pisu M, Smith JL, Prayor-Patterson H, Houston P, Watson C, Hullett S, Martin MY. Recruitment of low income, predominantly minority cancer survivors to a randomized trial of the I Can Cope cancer education program. J Health Care Poor Underserved. 2011 Aug;22(3):912-24. doi: 10.1353/hpu.2011.0069.

Reference Type BACKGROUND
PMID: 21841287 (View on PubMed)

Schoenberger YM, Benz R, McNees P, Meneses K. Patient-centered outcome evaluation of the Rural Breast Cancer Survivors Intervention. Support Care Cancer. 2016 Apr;24(4):1841-8. doi: 10.1007/s00520-015-2974-4. Epub 2015 Oct 9.

Reference Type BACKGROUND
PMID: 26452487 (View on PubMed)

Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, Snyder DC, Giguere JK, Shaw E. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008 Feb;8(1):70-9. doi: 10.3816/CBC.2008.n.005.

Reference Type BACKGROUND
PMID: 18501061 (View on PubMed)

Demark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Snyder DC, Sloane R, Peterson B, Macri JM, Rock CL, McBride CM, Kraus WE. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007 Jul 1;25(19):2709-18. doi: 10.1200/JCO.2007.10.7094.

Reference Type BACKGROUND
PMID: 17602076 (View on PubMed)

Demark-Wahnefried W, Clipp EC, Morey MC, Pieper CF, Sloane R, Snyder DC, Cohen HJ. Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD. J Clin Oncol. 2006 Jul 20;24(21):3465-73. doi: 10.1200/JCO.2006.05.7224.

Reference Type BACKGROUND
PMID: 16849763 (View on PubMed)

Demark-Wahnefried W, Jones LW, Snyder DC, Sloane RJ, Kimmick GG, Hughes DC, Badr HJ, Miller PE, Burke LE, Lipkus IM. Daughters and Mothers Against Breast Cancer (DAMES): main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters. Cancer. 2014 Aug 15;120(16):2522-34. doi: 10.1002/cncr.28761. Epub 2014 May 7.

Reference Type BACKGROUND
PMID: 24804802 (View on PubMed)

Adams RN, Mosher CE, Blair CK, Snyder DC, Sloane R, Demark-Wahnefried W. Cancer survivors' uptake and adherence in diet and exercise intervention trials: an integrative data analysis. Cancer. 2015 Jan 1;121(1):77-83. doi: 10.1002/cncr.28978. Epub 2014 Aug 25.

Reference Type BACKGROUND
PMID: 25155573 (View on PubMed)

Durant RW, Wenzel JA, Scarinci IC, Paterniti DA, Fouad MN, Hurd TC, Martin MY. Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer. 2014 Apr 1;120 Suppl 7(0 7):1097-105. doi: 10.1002/cncr.28574.

Reference Type BACKGROUND
PMID: 24643647 (View on PubMed)

Demark-Wahnefried W, Bowen DJ, Jabson JM, Paskett ED. Scientific bias arising from sampling, selective recruitment, and attrition: the case for improved reporting. Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):415-8. doi: 10.1158/1055-9965.EPI-10-1169.

Reference Type BACKGROUND
PMID: 21382981 (View on PubMed)

Snyder DC, Morey MC, Sloane R, Stull V, Cohen HJ, Peterson B, Pieper C, Hartman TJ, Miller PE, Mitchell DC, Demark-Wahnefried W. Reach out to ENhancE Wellness in Older Cancer Survivors (RENEW): design, methods and recruitment challenges of a home-based exercise and diet intervention to improve physical function among long-term survivors of breast, prostate, and colorectal cancer. Psychooncology. 2009 Apr;18(4):429-39. doi: 10.1002/pon.1491.

Reference Type BACKGROUND
PMID: 19117329 (View on PubMed)

Fowke JH, Schlundt D, Signorello LB, Ukoli FA, Blot WJ. Prostate cancer screening between low-income African-American and Caucasian men. Urol Oncol. 2005 Sep-Oct;23(5):333-40. doi: 10.1016/j.urolonc.2005.01.002.

Reference Type BACKGROUND
PMID: 16144667 (View on PubMed)

Fowke JH, Signorello LB, Underwood W 3rd, Ukoli FA, Blot WJ. Obesity and prostate cancer screening among African-American and Caucasian men. Prostate. 2006 Sep 15;66(13):1371-80. doi: 10.1002/pros.20377.

Reference Type BACKGROUND
PMID: 16752375 (View on PubMed)

Murff HJ, Peterson NB, Fowke JH, Hargreaves M, Signorello LB, Dittus RS, Zheng W, Blot WJ. Colonoscopy screening in African Americans and Whites with affected first-degree relatives. Arch Intern Med. 2008 Mar 24;168(6):625-31. doi: 10.1001/archinte.168.6.625.

Reference Type BACKGROUND
PMID: 18362255 (View on PubMed)

Barocas DA, Gray DT, Fowke JH, Mercaldo ND, Blume JD, Chang SS, Cookson MS, Smith JA Jr, Penson DF. Racial variation in the quality of surgical care for prostate cancer. J Urol. 2012 Oct;188(4):1279-85. doi: 10.1016/j.juro.2012.06.037. Epub 2012 Aug 16.

Reference Type BACKGROUND
PMID: 22902011 (View on PubMed)

Barocas DA, Grubb R 3rd, Black A, Penson DF, Fowke JH, Andriole G, Crawford ED. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer. 2013 Jun 15;119(12):2223-9. doi: 10.1002/cncr.28042. Epub 2013 Apr 4.

Reference Type BACKGROUND
PMID: 23559420 (View on PubMed)

Mandal DM, Sartor O, Halton SL, Mercante DE, Bailey-Wilson JE, Rayford W. Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history. Prostate Cancer Prostatic Dis. 2008;11(3):274-9. doi: 10.1038/pcan.2008.5. Epub 2008 Feb 12.

Reference Type BACKGROUND
PMID: 18268528 (View on PubMed)

Carpenter WR, Godley PA, Clark JA, Talcott JA, Finnegan T, Mishel M, Bensen J, Rayford W, Su LJ, Fontham ET, Mohler JL. Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use. Cancer. 2009 Nov 1;115(21):5048-59. doi: 10.1002/cncr.24539.

Reference Type BACKGROUND
PMID: 19637357 (View on PubMed)

Rayford W. Managing the low-socioeconomic-status prostate cancer patient. J Natl Med Assoc. 2006 Apr;98(4):521-30.

Reference Type BACKGROUND
PMID: 16623064 (View on PubMed)

McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994 Jan;32(1):40-66. doi: 10.1097/00005650-199401000-00004.

Reference Type BACKGROUND
PMID: 8277801 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01CA242737-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

300002068-B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Active After Cancer Trial (AACT)
NCT00548236 ACTIVE_NOT_RECRUITING NA